Submitted by webmaster on November 3, 2016 video here; Official Site S1500: A Randomized Phase 2 assessment of MET inhibitors in metastatic PRCCStart/End Date May 3, 2016 to November 3, 2016Cancer Types pIRCCpIIRCCTreatment Sunitinib, VolitinibPhase Phase 2 Add new comment Your name Subject Comment * More information about text formatsPlain textNo HTML tags allowed.Web page addresses and e-mail addresses turn into links automatically.Lines and paragraphs break automatically. Leave this field blank
Add new comment